CADIMA vs EPPI-Reviewer
CADIMA
cadima.infoEPPI-Reviewer
eppi.ioe.ac.ukSide by side
| Figure | CADIMA | EPPI-Reviewer |
|---|---|---|
| Price from | Free | £10/mo |
| Free plan | Yes | — |
| Free trial | — | Yes |
| Open source | — | — |
| Web | Yes | Yes |
| Plans published | 1 | 4 |
| Spec score · Literature Review Software | 7.8 (#14) | 7.9 (#10) |
| Spec score · Systematic Review Software | 7.8 (#17) | 7.9 (#14) |
| Headquarters | Quedlinburg, Germany | London, UK |
| Purpose | CADIMA is a free web tool for conducting and documenting systematic reviews, systematic maps, and other literature reviews. | EPPI-Reviewer is web-based software for managing and analysing literature-review data, including systematic reviews and meta-analyses. |
Plans
EPPI-Reviewer
- User fee£10 a month
- Shareable review fee£35 a month
- Direct support — hourly£80, paid once
- Direct support — full day£500, paid once
In their own words
CADIMA
CADIMA is a free web application for planning, conducting, and documenting systematic reviews, systematic maps, and other literature reviews. It accepts review questions from any research discipline and lets review teams work together worldwide, with no stated limit on reviewers at different stages. During screening, records can be allocated automatically while allowing independent and parallel assessment. CADIMA removes duplicate records automatically and supports bulk PDF uploads. It records the review process in detail, while its evidence synthesis database provides guidance and hosts synthesis data. The site describes planned archiving for review and evidence-map data and modules. Access data are used for statistical purposes and are not passed to third parties, according to the privacy policy. A scientist-and-programmer team handles questions, and user feedback informs further development. CADIMA is published by the Julius Kühn-Institut in Quedlinburg, Germany. The footer identifies version 2.2.4.2, dated April 2023.
EPPI-Reviewer
EPPI-Reviewer has no write-up on Specifiction yet; its figures are above.